The Multibillion-Rand Industry Profiting from Primate Pain
Charles River Laboratories and other companies supply endangered long-tailed macaques from Mauritius to biomedical laboratories, where the animals are used in testing and ultimately killed. The industry claims macaques are invasive pests and that their capture can benefit conservation, but the article reports that Mauritius lacks a coordinated population-control policy and that commercial activity itself helps sustain macaque populations. Researchers describe alternatives—including organ-on-a-chip systems, computer modelling and virtual control groups—while regulators in the United States, Europe and India move toward reducing or ending animal testing. The piece argues that the industry’s ethical and conservation justifications are undermined by the animals’ suffering, the species’ declining numbers and the availability of alternative methods.
Haber tarzıYorumlayıcı
Investigative reporting includes factual evidence and expert views, but uses forceful, critical language arguing that the macaque trade is ethically unjustified and environmentally misleading.





